周 辰熹

研究成果

每年研究成果 1991 1999 2004 2005 2007 2010 2021 2024

• 46 Article
• 1 Letter
• 1 Patent

每年研究成果

每年研究成果

搜尋結果

• 2024

  Transplacental passage of nirmatrelvir in pregnant women with COVID-19

  Chuang, M. T., Su, M. T., Chou, C. H., Liang, Y. L., Tsai, H. F., Yu, P. H., Wu, M. H., Ko, W. C. & Tsai, P. Y., 2024 1月, 於: International Journal of Gynecology and Obstetrics. 164, 1, p. 351-353 3 p.

  研究成果: Article › 同行評審
  1 引文 斯高帕斯（Scopus）
• 2023

  Design and synthesis of pyrazole derivatives against neutrophilic inflammation

  Yu, K. H., Tien, K. W., Wang, W. C., Chi, C. H., Tsai, K. C., Chou, C. H., Hwang, T. L. & Hung, H. Y., 2023 12月 15, 於: European Journal of Medicinal Chemistry. 262, 115874.

  研究成果: Article › 同行評審

  • pyrazole 100%
  • Anti-Inflammatory Drug 44%
  • Anti-Inflammatory Agent 43%
  • Inflammation 40%
  • Reaction Half Life 32%
• 2022

  Durability of single tablet regimen for patients with HIV infection in Southern Taiwan: data from a real-world setting

  Chang, H. M., Chou, C. H. & Tsai, H. C., 2022 12月, 於: BMC infectious diseases. 22, 1, 2.

  研究成果: Article › 同行評審

  開啟存取

  • Treatment Failure 97%
  • Tablets 92%
  • HIV Infections 89%
  • Syphilis 71%
  • Emtricitabine 54%
  4 引文 斯高帕斯（Scopus）
• 2021

  Model-based simulation to support the extended dosing regimens of atezolizumab

  Chou, C. H. & Hsu, L. F., 2021 1月, 於: European Journal of Clinical Pharmacology. 77, 1, p. 87-93 7 p.

  研究成果: Article › 同行評審

  • Anniversaries and Special Events 60%
  • Non-Small Cell Lung Carcinoma 42%
  • Pharmacokinetics 35%
  • Carcinoma 31%
  • Safety 27%
  8 引文 斯高帕斯（Scopus）

• Outcomes after switching to BIC/FTC/TAF in patients with virological failure to protease inhibitors or non-nucleoside reverse transcriptase inhibitors: A real-world cohort study

  Chang, H. M., Chou, P. Y., Chou, C. H. & Tsai, H. C., 2021, 於: Infection and Drug Resistance. 14, p. 4877-4886 10 p.

  研究成果: Article › 同行評審

  開啟存取

  • imidazole mustard 100%
  • Reverse Transcriptase Inhibitors 74%
  • Protease Inhibitors 63%
  • Cohort Studies 41%
  • Viremia 11%
  13 引文 斯高帕斯（Scopus）

• Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation

  Juang, S. H., Hsieh, M. T., Hsu, P. L., Chen, J. L., Liu, H. K., Liang, F. P., Kuo, S. C., Chiu, C. Y., Liu, S. H., Chou, C. H., Wu, T. S. & Hung, H. Y., 2021 1月 1, 於: Molecules. 26, 1, 164.

  研究成果: Article › 同行評審

  開啟存取

  • constitutive androstane receptor 100%
  • Androstane 98%
  • Coumarins 92%
  • Coumarin 68%
  • activation 52%
  3 引文 斯高帕斯（Scopus）
• 2020

  Modification of hospital ambulatory pharmacy patient flow in response to the covid-19 pandemic at a hospital in Taiwan

  Chang, H. M., Chen, M. T., Lee, E. K. L., Tsai, H. C. & Chou, C. H., 2020 9月, 於: Southeast Asian Journal of Tropical Medicine and Public Health. 51, 5, p. 663-666 4 p.

  研究成果: Article › 同行評審

  • Pandemics 100%
  • Pharmacy 94%
  • Taiwan 78%
  • acceptance 22%
  • Veterans Hospitals 21%
• 2015

  Association between ABCB1 polymorphisms and antidepressant treatment response in Taiwanese major depressive patients

  Chang, H. H., Chou, C. H., Yang, Y. K., Lee, I. H. & Chen, P. S., 2015 12月, 於: Clinical Psychopharmacology and Neuroscience. 13, 3, p. 250-255 6 p.

  研究成果: Article › 同行評審

  開啟存取

  • Antidepressive Agents 100%
  • Major Depressive Disorder 72%
  • Hydrocortisone 36%
  • Depression 36%
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 30%
  16 引文 斯高帕斯（Scopus）
• 2014

  Detection and distribution of endogenous steroids in human stratum corneum

  Tseng, S. P., Lu, C. C., Liao, P. C., Chou, C. H., Sheu, H. M. & Tsai, J. C., 2014 3月, 於: Dermatologica Sinica. 32, 1, p. 19-24 6 p.

  研究成果: Article › 同行評審

  開啟存取

  • Cortisone 100%
  • Cornea 87%
  • Steroids 69%
  • Hydrocortisone 61%
  • Forearm 33%
  3 引文 斯高帕斯（Scopus）
• 2013

  Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation

  Roan, J. N., Chou, C. H., Hsu, C. H., Wu, H. Y., Huang, Y. C., Yang, Y. J. & Luo, C. Y., 2013, 於: Annals of Transplantation. 18, 1, p. 45-52 8 p.

  研究成果: Article › 同行評審

  • Tacrolimus 92%
  • mycophenolic acid glucuronide 21%
  • Area Under Curve 14%
  • Leukopenia 6%
  • Organ Transplantation 6%
  8 引文 斯高帕斯（Scopus）

• Lauroyl/Palmitoyl glycol chitosan gels enhance skin delivery of magnesium ascorbyl phosphate

  Wang, P. C., Huang, Y. L., Hou, S. S., Chou, C. H. & Tsai, J. C., 2013 7月 1, 於: Journal of Cosmetic Science. 64, 4, p. 273-286 14 p.

  研究成果: Article › 同行評審

  • magnesium phosphate 71%
  • Glycol 40%
  • Magnesium Atom 36%
  • Chitosan 36%
  • Gels 36%
  8 引文 斯高帕斯（Scopus）
• 2012

  High risk of cross-reactivity between vancomycin and sequential teicoplanin therapy

  Hsiao, S. H., Chou, C. H., Lin, W. L., Lee, E. J., Liao, L. H., Chang, H. J., Yeh, P. Y., Lin, C. Y. & Wu, T. J., 2012 6月, 於: Journal of Clinical Pharmacy and Therapeutics. 37, 3, p. 296-300 5 p.

  研究成果: Article › 同行評審

  開啟存取

  • Teicoplanin 100%
  • Vancomycin 77%
  • Neutropenia 24%
  • Glycopeptides 23%
  • Drug-Related Side Effects and Adverse Reactions 17%
  23 引文 斯高帕斯（Scopus）
• 2010

  C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients

  Chang, H. H., Gean, P. W., Chou, C. H., Yang, Y. K., Tsai, H. C., Lu, R. B. & Chen, P. S., 2010 10月, 於: Journal of Clinical Psychopharmacology. 30, 5, p. 512-517 6 p.

  研究成果: Article › 同行評審

  • Valproic Acid 100%
  • Bipolar Disorder 88%
  • Leptin 52%
  • Genes 36%
  • GTP-Binding Proteins 26%
  23 引文 斯高帕斯（Scopus）

• HPLC-fluorescence assay for measuring mosapride in small volumes of rat plasma

  Cheng, C. L., Chang, Y. W. & Chou, C. H., 2010 3月, 於: Biomedical Chromatography. 24, 3, p. 281-288 8 p.

  研究成果: Article › 同行評審

  • Cisapride 100%
  • mosapride 95%
  • Plasma Volume 67%
  • Prokinetic Agent 51%
  • acetonitrile 46%
  2 引文 斯高帕斯（Scopus）

• Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: A case report and literature review

  Hsiao, S. H., Chen, H. H., Chou, C. H., Lin, W. L., Liu Yeh, P. Y. & Wu, T. J., 2010 12月, 於: Journal of Clinical Pharmacy and Therapeutics. 35, 6, p. 729-732 4 p.

  研究成果: Article › 同行評審

  開啟存取

  • Teicoplanin 100%
  • Vancomycin 77%
  • Neutropenia 73%
  • Hypersensitivity 60%
  • Lymphadenopathy 15%
  15 引文 斯高帕斯（Scopus）
• 2009

  High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan

  Chang, H. H., Chou, C. H., Chen, P. S., Gean, P. W., Huang, H. C., Lin, C. Y., Yang, Y. K. & Lu, R. B., 2009 9月, 於: Journal of Affective Disorders. 117, 1-2, p. 124-129 6 p.

  研究成果: Article › 同行評審

  • Bipolar Disorder 97%
  • Taiwan 84%
  • outpatient clinic 46%
  • intervention strategy 35%
  • morbidity 34%
  62 引文 斯高帕斯（Scopus）

• Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii

  Chiang, S. R., Chuang, Y. C., Tang, H. J., Chen, C. C., Chen, C. H., Lee, N. Y., Chou, C. H. & Ko, W. C., 2009 9月, 於: Critical care medicine. 37, 9, p. 2590-2595 6 p.

  研究成果: Article › 同行評審

  • Colistin 100%
  • Acinetobacter baumannii 95%
  • Carbapenems 90%
  • Pneumonia 63%
  • Sulbactam 41%
  25 引文 斯高帕斯（Scopus）
• 2007

  Amelioration of collagen-induced arthritis in rats by Nanogold

  Tsai, C. Y., Shiau, A. L., Chen, S. Y., Chen, Y. H., Cheng, P. C., Chang, M. Y., Chen, D. H., Chou, C. H., Wang, C. R. & Wu, C. L., 2007 2月, 於: Arthritis and Rheumatism. 56, 2, p. 544-554 11 p.

  研究成果: Article › 同行評審

  • Experimental Arthritis 100%
  • Rheumatoid Arthritis 69%
  • Ankle Joint 32%
  • Macrophages 29%
  • Microvessels 28%
  191 引文 斯高帕斯（Scopus）

• Determination of norfloxacin in rat liver perfusate using capillary electrophoresis with laser-induced fluorescence detection

  Cheng, C. L., Fu, C. H. & Chou, C. H., 2007 9月 1, 於: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 856, 1-2, p. 381-385 5 p.

  研究成果: Article › 同行評審

  • Capillary Electrophoresis With Laser-Induced Fluorescence Detection 100%
  • Capillary Electrophoresis 86%
  • Norfloxacin 85%
  • Fluorescence 54%
  • Lasers 53%
  28 引文 斯高帕斯（Scopus）

• Development and validation of a high-performance liquid chromatographic method using fluorescence detection for the determination of vardenafil in small volumes of rat plasma and bile

  Cheng, C. L., Kang, G. J. & Chou, C. H., 2007 6月 22, 於: Journal of Chromatography A. 1154, 1-2, p. 222-229 8 p.

  研究成果: Article › 同行評審

  • Vardenafil 100%
  • Vardenafil Dihydrochloride 92%
  • Plasma Volume 71%
  • Bile 59%
  • Fluorescence 48%
  26 引文 斯高帕斯（Scopus）

• Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model

  Chen, Y. H., Tsai, C. Y., Huang, P. Y., Chang, M. Y., Cheng, P. C., Chou, C. H., Chen, D. H., Wang, C. R., Shiau, A. L. & Wu, C. L., 2007 9月, 於: Molecular Pharmaceutics. 4, 5, p. 713-722 10 p.

  研究成果: Article › 同行評審

  • Methotrexate 100%
  • Gold 81%
  • Nanoparticles 71%
  • Gold Nanoparticle 66%
  • Lung 42%
  356 引文 斯高帕斯（Scopus）
• 2005

  Aqueous dispersions of magnetite nanoparticles with NH₃ ⁺ surfaces for magnetic manipulations of biomolecules and MRI contrast agents

  Shieh, D. B., Cheng, F. Y., Su, C. H., Yeh, C. S., Wu, M. T., Wu, Y. N., Tsai, C. Y., Wu, C. L., Chen, D. H. & Chou, C. H., 2005 12月, 於: Biomaterials. 26, 34, p. 7183-7191 9 p.

  研究成果: Article › 同行評審

  • Magnetite nanoparticles 100%
  • Magnetite Nanoparticles 94%
  • Biomolecules 78%
  • Dispersions 73%
  • Magnetite Nanoparticle 66%
  113 引文 斯高帕斯（Scopus）

• Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography

  Cheng, C. L., Chou, C. H. & Hu, O. Y. P., 2005 3月 25, 於: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 817, 2, p. 199-206 8 p.

  研究成果: Article › 同行評審

  • Lamotrigine 100%
  • Plasma Volume 77%
  • High-Pressure Liquid Chromatography 49%
  • Plasma 40%
  • Guanabenz 38%
  64 引文 斯高帕斯（Scopus）

• Determination of tadalafil in small volumes of plasma by high-performance liquid chromatography with UV detection

  Cheng, C. L. & Chou, C. H., 2005 8月 5, 於: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 822, 1-2, p. 278-284 7 p.

  研究成果: Article › 同行評審

  • Tadalafil 100%
  • Plasma Volume 75%
  • High-Pressure Liquid Chromatography 48%
  • Plasma 39%
  • Volume 36%
  47 引文 斯高帕斯（Scopus）
• 2004

  A biological strategy for fabrication of Au/EGFP nanoparticle conjugates retaining bioactivity

  Tsai, C. Y., Shiau, A. L., Cheng, P. C., Shieh, D. B., Chen, D. H., Chou, C. H., Yeh, C. S. & Wu, C. L., 2004 7月, 於: Nano letters. 4, 7, p. 1209-1212 4 p.

  研究成果: Article › 同行評審

  • Gold nanoparticles 100%
  • Bioactivity 85%
  • retaining 69%
  • DNA 65%
  • deoxyribonucleic acid 57%
  40 引文 斯高帕斯（Scopus）

• A Nonviral Transfection Approach in Vitro: The Design of a Gold Nanoparticle Vector Joint with Microelectromechanical Systems

  Jen, C. P., Chen, Y. H., Fan, C. S., Yeh, C. S., Lin, Y. C., Shieh, D. B., Wu, C. L., Chen, D. H. & Chou, C. H., 2004 2月 17, 於: Langmuir. 20, 4, p. 1369-1374 6 p.

  研究成果: Article › 同行評審

  • Electroporation 100%
  • Gold nanoparticles 99%
  • oligonucleotides 88%
  • Oligonucleotides 75%
  • Nanocarrier 68%
  56 引文 斯高帕斯（Scopus）

• A validated HPLC method with ultraviolet detection for the determination of buformin in plasma

  Chou, C. H., Cheng, C. L. & Huang, C. C., 2004 5月, 於: Biomedical Chromatography. 18, 4, p. 254-258 5 p.

  研究成果: Article › 同行評審

  • Buformin 100%
  • Metformin 37%
  • Plasma 32%
  • ammonium phosphate 30%
  • Diammonium Hydrogen Phosphate 27%
  3 引文 斯高帕斯（Scopus）

• Biowaiver extension potential to BCS Class III high solubility-low permeability drugs: Bridging evidence for metformin immediate-release tablet

  Cheng, C. L., Yu, L. X., Lee, H. L., Yang, C. Y., Lue, C. S. & Chou, C. H., 2004 7月, 於: European Journal of Pharmaceutical Sciences. 22, 4, p. 297-304 8 p.

  研究成果: Article › 同行評審

  • Metformin 74%
  • Solubility 68%
  • Tablets 63%
  • Permeability 59%
  • Therapeutic Equivalency 52%
  141 引文 斯高帕斯（Scopus）

• Evaluation of In Vivo Bioequivalence Methodology for Topical Clobetasol 17-Propionate Based on Pharmacodynamic Modeling Using Chinese Skin

  Tsai, J. C., Cheng, C. L., Tsai, Y. F., Sheu, H. M. & Chou, C. H., 2004 1月, 於: Journal of Pharmaceutical Sciences. 93, 1, p. 207-217 11 p.

  研究成果: Article › 同行評審

  • Clobetasol 100%
  • Therapeutic Equivalency 63%
  • Emax 47%
  • Ointment 42%
  • Dose 38%
  19 引文 斯高帕斯（Scopus）

• Refractory candidal meningitis in an immunocompromised patient cured by caspofungin

  Liu, K. H., Wu, C. J., Chou, C. H., Lee, H. C., Lee, N. Y., Hung, S. T. & Ko, W. C., 2004 12月, 於: Journal of Clinical Microbiology. 42, 12, p. 5950-5953 4 p.

  研究成果: Article › 同行評審

  開啟存取

  • Caspofungin 100%
  • Immunocompromised Host 76%
  • Meningitis 72%
  • Amphotericin B 63%
  • Cerebrospinal Fluid 50%
  43 引文 斯高帕斯（Scopus）
• 2003

  In vitro and in vivo comparison of two diclofenac sodium sustained release oral formulations

  Su, S. F., Chou, C. H., Kung, C. F. & Huang, J. D., 2003 7月 9, 於: International Journal of Pharmaceutics. 260, 1, p. 39-46 8 p.

  研究成果: Article › 同行評審

  • Diclofenac Sodium 100%
  • Delayed-Action Preparations 92%
  • Diclofenac 88%
  • In Vitro Techniques 32%
  • Pharmacokinetics 28%
  37 引文 斯高帕斯（Scopus）

• Rapid and sensitive quantitation of the antiproliferative agent mitoguazone in small volumes of plasma by high-performance liquid chromatography with ultraviolet detection

  Cheng, C. L., Lin, E. G. & Chou, C. H., 2003 8月 15, 於: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 793, 2, p. 281-289 9 p.

  研究成果: Article › 同行評審

  • Mitoguazone 100%
  • Plasma Volume 57%
  • Antiproliferative 47%
  • Amiloride 40%
  • High-Pressure Liquid Chromatography 36%
  3 引文 斯高帕斯（Scopus）
• 2002

  Determination of delavirdine in very small volumes of plasma by high-performance liquid chromatography with fluorescence detection

  Cheng, C. L., Chou, C. H. & Hu, O. Y. P., 2002 4月 5, 於: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 769, 2, p. 297-303 7 p.

  研究成果: Article › 同行評審

  • Delavirdine 100%
  • Plasma Volume 65%
  • Cisapride 64%
  • acetonitrile 45%
  • Fluorescence 44%
  7 引文 斯高帕斯（Scopus）

• Relationship between lipophilicity and protein binding of a homologous series of barbiturates

  Chou, C. H. & Rowland, M., 2002, 於: Chinese Pharmaceutical Journal. 54, 2, p. 87-94 8 p.

  研究成果: Article › 同行評審

  • Barbiturates 100%
  • Barbiturate 99%
  • Homologous Sery 82%
  • Lipophilicity 81%
  • Protein Binding 76%
• 2001

  A pharmacokinetic study of nimesulide in healthy volunteers: Correlation between in vitro dissolution and in vivo absorption

  Su, S. F., Huang, J. D., Chou, C. H., Chu, C. W., Hsiao, C. L., Kung, C. F., Lee, H. L. & Yang, C. Y., 2001 12月 1, 於: Chinese Pharmaceutical Journal. 53, 6, p. 281-290 10 p.

  研究成果: Article › 同行評審

  • Nimesulide 100%
  • nimesulide 97%
  • Pharmacokinetics 49%
  • Dissolution 49%
  • Healthy Volunteers 44%

• Determination of metformin in human plasma by high-performance liquid chromatography with spectrophotometric detection

  Cheng, C. L. & Chou, C. H., 2001 10月 5, 於: Journal of Chromatography B: Biomedical Sciences and Applications. 762, 1, p. 51-58 8 p.

  研究成果: Article › 同行評審

  • High-Pressure Liquid Chromatography 53%
  • Atenolol 47%
  • Plasma 43%
  • Diammonium Hydrogen Phosphate 27%
  • Acetonitrile 24%
  118 引文 斯高帕斯（Scopus）
• 2000

  Uptake and dispersion of metformin in the isolated perfused rat liver

  Chou, C. H., 2000, 於: Journal of Pharmacy and Pharmacology. 52, 8, p. 1011-1016 6 p.

  研究成果: Article › 同行評審

  • Metformin 75%
  • Liver 36%
  • Vd 18%
  • Metformin Hydrochloride 10%
  • Antidiabetic Agent 7%
  22 引文 斯高帕斯（Scopus）
• 1999

  Bioequivalence study of two tablet formulations of metformin HC1 in healthy Chinese volunteers

  Cheng, C. L., Lee, H. L., Yang, C. Y. & Chou, C. H., 1999 12月 1, 於: Journal of Pharmacy and Pharmacology. 51, SUPPL., 1 p.

  研究成果: Article › 同行評審

• Determination of metformin in human plasma by high-performance liquid chromatography

  Cheng, C. L. & Chou, C. H., 1999, 於: Journal of Pharmacy and Pharmacology. 51, SUPPL., p. 82 1 p.

  研究成果: Article › 同行評審
  1 引文 斯高帕斯（Scopus）

• Hepatic uptake and dispersion of metformin in the isolated perfused rat liver

  Cheng, C. L., Wang, H. Y. & Chou, C-H., 1999 12月 1, 於: Journal of Pharmacy and Pharmacology. 51, SUPPL., 1 p.

  研究成果: Article › 同行評審
• 1998

  Optimal experimental design for precise estimation of the parameters of the axial dispersion model of hepatic elimination

  Chou, C. H., Aarons, L. & Rowland, M., 1998, 於: Journal of Pharmacokinetics and Biopharmaceutics. 26, 5, p. 595-615 21 p.

  研究成果: Article › 同行評審

  • Hepatobiliary Elimination 100%
  • Research Design 63%
  • Pharmaceutical Preparations 33%
  • Carrier Proteins 16%
  4 引文 斯高帕斯（Scopus）
• 1997

  Effect of altered tissue binding on the disposition of barbital in the isolated perfused rat liver: Application of the axial dispersion model

  Chou, C. H. & Rowland, M., 1997 11月, 於: Journal of Pharmaceutical Sciences. 86, 11, p. 1310-1314 5 p.

  研究成果: Article › 同行評審

  • Barbital 100%
  • Barbiturate 85%
  • barbituric acid 53%
  • Liver 33%
  • Water 21%
  10 引文 斯高帕斯（Scopus）
• 1995

  Membrane permeability and lipophilicity in the isolated perfused rat liver: 5-Ethyl barbituric acid and other compounds

  Chou, C-H., McLachlan, A. J. & Rowland, M., 1995 12月 1, 於: Journal of Pharmacology and Experimental Therapeutics. 275, 2, p. 933-940 8 p.

  研究成果: Article › 同行評審

  • barbituric acid 100%
  • Permeability 66%
  • Membranes 45%
  • Liver 39%
  • Sucrose 32%
  35 引文 斯高帕斯（Scopus）
• 1994

  P158 effect of temperature on the distribution of barbiturate in isolated perfused rat liver

  Chou, C-H. & Rowland, M., 1994 1月 1, 於: European Journal of Pharmaceutical Sciences. 2, 1-2, 1 p.

  研究成果: Article › 同行評審
• 1993

  Relationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver

  Chou, C. H., Evans, A. M., Fornasini, G. & Rowland, M., 1993 1月 1, 於: Drug Metabolism and Disposition. 21, 5, p. 933-938 6 p.

  研究成果: Article › 同行評審

  • Barbiturates 100%
  • Barbiturate 99%
  • Homologous Sery 82%
  • Lipophilicity 81%
  • barbituric acid 59%
  51 引文 斯高帕斯（Scopus）
• 1991

  Determination of vecuronium in blood by HPLC with UV and electrochemical detection: a pilot study in man.

  Hu, O. Y., Chou, C. H., Ho, W. & Ho, S. T., 1991 7月, 於: Proceedings of the National Science Council, Republic of China. Part B, Life sciences. 15, 3, p. 186-190 5 p.

  研究成果: Article › 同行評審

  • Vecuronium Bromide 100%
  • Electrodes 18%
  • Innovar 17%
  • Liquid-Liquid Extraction 16%
  • Pharmacokinetics 15%
  4 引文 斯高帕斯（Scopus）